Relay Therapeutics, Inc. Prepaid Expense, Current
Relay Therapeutics, Inc. (RLAY) had Prepaid Expense, Current of $8.73 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense, Current $8.73M.
- 2026-03-31: Prepaid Expense, Current $11.84M.
- 2025-12-31: Prepaid Expense, Current $17.79M.
- 2025-09-30: Prepaid Expense, Current $23.84M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2026-06-30 | $8.73M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $11.84M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $17.79M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $23.84M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $16.04M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $21.95M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $17.35M 10-K · filed 2026-02-26 |
| 2024-09-30 | $18.73M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $10.12M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $13.19M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $16.70M 10-K · filed 2025-02-26 |
| 2023-09-30 | $17.29M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $9.31M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $11.27M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $12.11M 10-K · filed 2024-02-22 |
| 2022-09-30 | $16.81M 10-Q · filed 2022-11-03 |
| 2021-12-31 | $11.46M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |